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The naturally occurring sex difference in dendritic
spine number on hypothalamic neurons offers a
unique opportunity to investigate mechanisms es-
tablishing synaptic patterning during perinatal sensi-
tive periods. A major advantage of the rat as a model
of sexual differentiation is that treatment of neonatal
females with estradiol will permanently induce the
male phenotype. During the development of other
systems, exuberant innervation is followed by ac-
tivity-dependent pruning necessary for elimination
of spurious synapses. In contrast, we demonstrate
that estradiol-induced organization in the hypothala-
mus involves the induction of new synapses on den-
dritic spines. Activation of estrogen receptors by es-
tradiol triggers a nongenomic activation of PI3 kinase
that results in enhanced glutamate release from pre-
synaptic neurons. Subsequent activation of iono-
tropic glutamate receptors activates MAP kinases,
thereby inducing dendritic spine formation. These
results reveal a transneuronal mechanism by which
estradiol acts during a sensitive period to establish
a profound and lasting sex difference in hypotha-
lamic synaptic patterning.
INTRODUCTION
Determining the mechanisms underlying the formation of func-
tional neuronal circuits is central to understanding brain develop-
ment. Variation in neuronal activity, hormonal milieu, or environ-
mental cues can permanently change the formation of specific
circuits and the phenotype of individual neurons during a devel-
opmental sensitive period. This concept is well established in the
visual cortex (Desai et al., 2002; Wong, 1999; Zhang and Poo,
2001), motor neuron circuits (Hanson and Landmesser, 2004;
Haverkamp and Oppenheim, 1986), and the song control circuit
in birds (Iyengar and Bottjer, 2002), in which light, movement, or
sound, respectively, affect spontaneous activity in the neurons
and in so doing establish the proper synaptic connections for584 Neuron 58, 584–598, May 22, 2008 ª2008 Elsevier Inc.optimal function. Appropriate synaptic connectionsmust also be
achieved in male and female brains wherein fundamental neuro-
nal differences mediate the well-known sex differences in phys-
iology and behavior. In rodents, these sex differences are deter-
mined during a critical period of development by estradiol, which
is aromatized from testicular androgens in the male (Naftolin
et al., 1971). Early estradiol exposure permanently differentiates
the male from the female rodent brain by establishing sex differ-
ences in synaptic connections and neuronal morphology that
affect behavior (De Vries and Simerly, 2002; McCarthy, 2008).
Dendritic spines are anatomical loci of excitatory synapses on
neurons. Spine formation and maintenance are sensitive to both
electrical and chemical stimulation. Estradiol is an important
regulator ofdendritic spines inmanybrain regionsduringdevelop-
ment (AmateauandMcCarthy, 2002b;MatsumotoandArai, 1980,
1986b; Pozzo Miller and Aoki, 1991; Todd et al., 2005) and adult-
hood (Calizo and Flanagan-Cato, 2000; Carrer and Aoki, 1982;
Murphy and Segal, 1996; Woolley and McEwen, 1992), thereby
influencing behavior and reproductive function. In newborn rats,
males have twice the number of dendritic spines on hypothalamic
neurons as females, and treatment of females at birth with testos-
terone, which is centrally aromatized to estradiol in the brain,
increases the number of dendritic spines to that of males (Todd
et al., 2007). However, the mechanism or mechanisms by which
estradiol permanently organizes a sex difference in dendritic
spines in themedial basal hypothalamus (MBH) remain unknown.
The classic model of estradiol action involves ligand binding to
a nuclear receptor, dimerization and recruitment of coactivators,
and initiation of gene transcription at estrogen response ele-
ments (ERE) found in the promoter region of estrogen-respon-
sive genes. Estrogen receptors (ER) aremembers of a superfam-
ily of nuclear transcription factors that regulate gene expression
(Beato, 1989; Uht et al., 1997). Dense concentrations of ER are
found in neonatal hypothalamic neurons of males and females
(Shughrue et al., 1997; Simerly et al., 1990) and are directly linked
to sexual differentiation of the brain (McCarthy et al., 1993;
McEwen et al., 1977; Quadros et al., 2002). Activated ER can
also indirectly promote gene transcription independent of
EREs via activation of kinases that in turn activate specific
promoter elements. In the hypothalamus, ligand-bound ER
activates protein kinase A (PKA), CREB (Abraham and Herbison,
2005; Aronica et al., 1994; Lee et al., 2004; Zhou et al., 1996), the
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et al., 1999), and phosphatidylinositol 3-kinase (PI3 kinase) (Zna-
mensky et al., 2003). Thus, ER activation can be localized to the
membrane, yet induce a host of effects that induce or facilitate
transcriptional activity dependent on or independent of the
ERE (Vasudevan and Pfaff, 2007). To date, membrane-initiated
effects of estradiol have not been reported in the developing
brain, and in fact would seem unlikely given that rapidmembrane
effects are presumed to be not conducive to permanent organi-
zational changes. We now report that estradiol promotes spine
formation in the developing hypothalamus via rapid, nonge-
nomic activation of PI3 kinase in presynaptic neurons, enhancing
glutamate release and glutamate receptor activation in postsyn-
aptic neurons. AMPA- and NMDA-receptor-dependent activa-
tion of postsynaptic MAP kinases then triggers a protein synthe-
sis-dependent increase in dendritic spine number.
RESULTS
Estradiol and NMDA Receptor Activation Increase
Dendritic Spine Number in the Developing
Hypothalamus to Establish a Sex Difference
On the day of birth, males had significantly more dendritic spines
on Golgi-Cox impregnated hypothalamic neurons than females
(main effect F3,19 = 8.80, p = 0.0007, post hoc p = 0.001; Fig-
ure 1A). Treatment of females with estradiol or NMDA for 6 hr sig-
nificantly increased the number of spines compared with that of
vehicle-treated females (p = 0.001) to levels equivalent with
those seen on male neurons. Further analysis of the Golgi-Cox
impregnated neurons revealed that the increase in spine number
was accompanied by an elongation of neuronal dendrites of
34% (F3,19 = 3.47, p = 0.036; Figure 1A). There was no difference
in the density of dendritic spines (data not shown).
Newborn males also had significantly more spinophilin protein
in the MBH than females, as determined by western blot analy-
sis, confirming the previously reported correlation between in-
creased dendritic spine number and increased spinophilin levels
(Amateau and McCarthy, 2002a, 2004; Todd et al., 2005, 2007).
Treatment of females with estradiol (250 mg) increased spinophi-
lin levels to those of males within 6 hr (F2, 15 = 15.8, p = 0.002;
Figure 1B). To determine whether the effect of estradiol on den-
dritic spines at 6 hr was maintained at later time points, brains
were also collected from animals 48 hr after a single injection
of estradiol. Spinophilin levels remained significantly elevated
48 hr after estradiol treatment compared with those of control
(F3,20 = 4.09, p = 0.031; Figure 1C) and were not different from
6 hr of estradiol exposure (p = 0.901), confirming that estra-
diol-induced dendritic spines are maintained for an extended
period of time. The MBH is thus sexually dimorphic at birth
with regard to spinophilin level and spine number, and the levels
seen in males can be induced in females by treatment with estra-
diol or activation of NMDA receptors.
Estradiol Increases Dendritic Spine Number
in the Developing Hypothalamus via Activation
of Ionotropic Glutamate Receptors
We hypothesized that activation of glutamate receptors is
necessary for the estradiol-induced increase in dendritic spinenumber in the developing hypothalamus. We first treated
animals with the AMPA-type glutamate receptor antagonist
NBQX (2.5 mg subcutaneously [s.c.]) prior to estradiol treatment;
NBQX prevented the estradiol-induced increase in spinophilin
(F3,17 = 7.04, p = 0.002; Figure 2A). Treatment with NBQX alone
had no effect. To determine if NMDA receptors are also required
for estradiol-induced spinophilin, animals were pretreated with
the NMDA receptor antagonist MK801 (10 mg s.c.) prior to estra-
diol treatment. MK801 completely blocked the estradiol-induced
increase in spinophilin (F3,13 = 13.29, p = 0.0003; Figure 2A).
Treatment with MK801 alone had no effect on spinophilin levels.
These results suggest that NMDA receptor activation is neces-
sary for estradiol to induce dendritic spines. The ability of NMDA
treatment in vivo to increase dendritic spines detected by Golgi
impregnation suggested that NMDA glutamate receptor activa-
tion is sufficient as well. We further confirmed this by treatment
of female pups on the day of birth with estradiol, NMDA (10 mg
s.c.), or vehicle. Direct activation of NMDA receptors mimicked
the effect of estradiol on spinophilin levels (F2,20 = 7.70, p =
0.002; Figure 2B). These data confirm the NMDA-mediated
increase in dendritic spines seen using Golgi impregnation
of VMN neurons (Figure 1A) and are consistent with previous
reports indicating that activation of AMPA receptors also in-
creases dendritic spines in the developing female hypothalamus
to the same degree as estradiol (Todd et al., 2007). We conclude
that estradiol does not induce increases in spinophilin protein
directly, but rather does so indirectly in a glutamate-receptor-
dependent manner. Furthermore, activation of glutamate recep-
tors is not only necessary but also sufficient to induce sex
differences in dendritic spine number in the developing hypo-
thalamus.
Estradiol Has No Effect on the Number or Function of
Glutamate Receptors in the Developing Hypothalamus
The pivotal observations from the previous experiments suggest
that activation of AMPA and NMDA receptors is required for
estradiol-induced increases in dendritic spine number. There
are two potential mechanisms by which this could occur: (1) es-
tradiol might alter the number or function of postsynaptic AMPA
and/or NMDA receptors, or (2) estradiol might act presynapti-
cally to promote glutamate release directly from hypothalamic
neurons.
To test the first hypothesis, male and female hypothalami were
assessed by quantitative western blot for levels of the AMPA re-
ceptor subunits GluR1 and GluR2 and the requisite NMDA sub-
unit, NR1. There was no sex difference in, and no effect of estra-
diol treatment on, the amount of GluR1 (F2,18 = 0.378, p = 0.690),
GluR2 (F2,16 = 0.488, p = 0.623), or NR1 (F2,14 = 0.788, p = 0.474)
in the neonatal MBH (Figure S1A, available online).
In another experiment females were treated with or without es-
tradiol (100 mg/0.1 ml sesame oil, s.c.) on postnatal day 0 (PN0),
1, and 2. Slices were made from the hypothalamus of these an-
imals on PN4–5, and AMPA-mediated miniature excitatory post-
synaptic currents (mEPSCs) were recorded from ventrolateral
VMN (vlVMN) neurons. Estradiol-induced dendritic spines are
fully established at this age (Matsumoto and Arai, 1986a) (Fig-
ure 3B). We found no significant effect of estradiol on the median
amplitude (t16 = 0.87, p = 0.238), frequency (t16 = 1.22,Neuron 58, 584–598, May 22, 2008 ª2008 Elsevier Inc. 585
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E2 Increases Spines by Enhancing Glutamate ReleaseFigure 1. Estradiol and NMDA Induce Dendritic Spines and Spinophilin in the MBH
(A) Golgi-Cox impregnated neurons were morphologically assessed (representative photomicrographs in left panels, scale bar = 10 mm). As shown in the right
panels, males had significantly more dendritic spines per dendrite and dendrites were significantly longer than those in females on the day of birth (ANOVA F3,19 =
8.8; *p < 0.005 compared with all other groups).
(B) (Left) A coronal schematic of the rodent brain is shown in the middle left panel (Paxinos and Watson, 2004). The rectangle indicates the outline of the medial
basal hypothalamus (MBH) dissection. (Right) Western blot for spinophilin indicates that males had higher levels than females on the day of birth, and treatment of
females with estradiol (E2) increased spinophilin to levels seen in males within 6 hr (ANOVA F3,19 = 3.47; *p < 0.05 compared with all other groups; n = 5–6 per
group).
(C) MBH tissue was collected at 6 or 48 hr post-estradiol (E2). Spinophilin was significantly elevated at both time points compared with that of controls (ANOVA
F3,20 = 4.09; *p < 0.05; n = 5–6 per group). There was no difference in spinophilin levels between vehicle-treated animals at 6 hr versus 48 hr (p = 0.90), and these
were collapsed into one group.
Graphical representation of dendritic spine and western blot analysis indicates the mean ± SEM for each treatment group.586 Neuron 58, 584–598, May 22, 2008 ª2008 Elsevier Inc.
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the developing hypothalamus (n = 8–10 cells from vehicle-
treated or estradiol-treated animals; Figure 3A). We conclude
that estradiol has no effect on the number of synaptic AMPA-
type glutamate receptors in these neurons. We also found no
effect on the computed ratio of synaptic AMPA-to-NMDA recep-
tors, seen by measuring the peak amplitude of EPSCs mediated
by AMPA receptors and the amplitude of the NMDA-receptor-
mediated component of the EPSC (p = 0.8, n = 7 cells from
each; (Figure 4A). Estradiol also had no effect on glutamate-
induced calcium responses in cultured hypothalamic neurons,
as measured with the fluorescent ratiometric calcium-sensitive
dye fura-2. We found no difference in either the number of neu-
rons that responded to glutamate (c2 = 1.65, p = 0.200) or the
peak amplitude of the calcium response to glutamate (K-S
test: c2 = 2.12, p = 0.697, Figure S1B).
Recorded neurons were filled with biocytin from a patch
pipette and their morphology was analyzed. Consistent with
the morphological analysis of Golgi-Cox impregnated neurons
(Figure 1A), neurons treated with estradiol had more dendritic
spines along the primary dendrite compared with those of
control (t7 = 2.67, p = 0.031), and the overall length of the dendrite
was greater (t7 = 2.41, p = 0.060; Figure 3B). There was no effect
of estradiol on the number of branches per dendrite or the
dendritic spine density (data not shown).
Figure 2. Glutamate Receptor Activation Is
Necessary and Sufficient for Estradiol-In-
duced Increases in Dendritic Spines
(A) (Left) Estradiol (E2) treatment induced a 3-fold
increase in spinophilin, and pretreatment with the
AMPA receptor antagonist NBQX completely
blocked the increase (ANOVA F3,17 = 7.04; *p <
0.05, compared with all other groups, n = 5–6
group). (Right) In a separate experiment, estradiol
again significantly increased spinophilin, and pre-
treatment with the NMDA receptor antagonist
MK801 also completely prevented the increase
(ANOVA F3,13 = 13.29; *p < 0.05 compared with
all other groups, n = 5–6 per group).
(B) Treatment of females on the day of birth with ei-
ther estradiol or NMDA to directly activate NMDA
receptors significantly increased spinophilin levels
within 6 hr (ANOVA F2,20 = 7.70; *p < 0.05 com-
pared with vehicle [Veh]; Veh: n = 9, E2: n = 9,
NMDA: n = 5).
Graphical representation of western blot analysis
indicates the mean ± SEM for each treatment
group.
Estradiol Enhances Presynaptic
Neurotransmitter Release from
Glutamatergic Terminals of
Developing Hypothalamic Neurons
Concluding that estradiol does not affect
glutamatergic transmission postsynapti-
cally, we hypothesized that estradiol
promotes presynaptic glutamate release
to increase dendritic spines. To test this
hypothesis, we measured whole-cell volt-
age-clamp recordings to compare the paired-pulse ratio (PPR) in
brain slices from female pups treated with or without estradiol for
up to 6 hr on PN2. The PPR is inversely correlated with release
probability (Zucker and Regehr, 2002). The amplitude of the
AMPA-receptor-mediated EPSC elicited in response to the second
of two stimuli delivered at an interstimulus interval of 50 ms was
considerably facilitated compared with the first EPSC in cells in
vehicle-treated slices (PPR=1.85± 0.21, n = 11). In cells fromestra-
diol-treatedslices, theamplitudeof thesecondEPSCwasalso facil-
itated,but toa significantly smaller extent (PPR=1.22± 0.09, n=12)
(t21 =2.72, p = 0.0127; Figure 4A). The decrease in the PPR in the
estradiol-treated slices is consistent with an estradiol-induced
increase in the probability of release at glutamatergic synapses.
We next used the fluorescent styryl dye FM4-64 to assay
the effects of estradiol on release probability more directly.
Presynaptic boutons were labeled with FM4-64 and the proba-
bility of transmitter release was assayed by the rate of FM4-64
destaining in response to either KCl-induced depolarization or
electrical field stimulation (Brager et al., 2003; Pyle et al., 1999;
Ryan et al., 1996) (Figure S2). Post hoc analysis of hypothalamic
neurons revealed 100% colocalization of FM4-64 staining and
vesicular glutamate transporter 2 (VGLUT2) immunostaining,
indicating the terminals analyzed for transmitter release were
glutamatergic (vehicle: n = 32 boutons; estradiol: n = 36 boutons
from two separate cultures; Figure 5A).Neuron 58, 584–598, May 22, 2008 ª2008 Elsevier Inc. 587
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significantly increased the total fluorescence lost after 30 s of
depolarization with either 50 mM KCl or stimulation at 1 Hz via
an electrode positioned near the imaged region, compared
with untreated cultures (F3,16 = 3.94, p = 0.027; Figure 5B). After
120 s of depolarization, the total fluorescence lost for all groups
was not significantly different (p = 0.223), indicating that the size
of the recycling vesicle pool was not affected by estradiol.
Treatment with the ER antagonist ICI 182,780 (i.e. ICI) alone
had no effect on the rate of destaining (p = 0.239; Figure 5C)
but completely prevented estradiol-induced enhancement of
FM4-64 destaining (F3,7 = 6.29, p = 0.032), indicating that estra-
diol-enhanced glutamate release requires activation of the ER.
There was no effect of estradiol treatment on the density of FM4-
64-labeledboutons (F3,25=0.86,p=0.470) or theareaof thesebou-
tons (F3,25=0.26,p=0.850)compared to thatofcontrols (FigureS3).
When analyzed separately, neurons treated with estradiol for
less than 2 hr showed an increase in neurotransmitter release
when compared with those that underwent vehicle treatment
Figure 3. Estradiol Has No Effect on mEPSC Amplitude
(A) (Left) Representative traces of mEPSCs recorded from neurons in
the VMN treated with or without estradiol for 2 days beginning at birth
and the corresponding cumulative probability plot (n.s., K-S test).
(Right) Estradiol treatment had no effect on the median amplitude
(pA) (t16 = 0.87; p = 0.238), frequency (Hz) (t16 = 1.22; p = 0.396),
or the decay time (ms) (t16 = 0.57; p = 0.572) of mEPSCs recorded
from these neurons (n = 8–10 neurons).
(B) Representative photomicrographs of an MBH slice used for re-
cording mEPSCs from ventrolateral VMN (vlVMN). Arrow indicates
a neuron filled with biocytin after recording. ARC, arcuate nucleus;
III, the third ventricle. Images immediately to the right show represen-
tative neurons that were recorded from and then filled with biocytin.
(Lower panels) Morphological analysis of biocytin-filled neurons in sli-
ces from females treated with estradiol for 48 hr at birth revealed an
increased number of dendritic spines along the primary dendrite
(t7 = 2.67; *p < 0.05 compared with vehicle [Veh]) and increased total
dendrite length (t8 = 2.41; *p < 0.05 compared with vehicle; Veh: n = 4
neurons, estradiol: n = 6 neurons).
Graphical representation of mEPSC and morphological analysis
indicates the mean ± SEM for each treatment group.
for the same amount of time (p = 0.05; Figure 5C inset),
demonstrating that estradiol rapidly enhances the release
of glutamate from developing hypothalamic neurons via
activation of classical ER. Notably, the increase in release
probability within 2 hr precedes the increase in the
number of dendritic spines, first detectable at 6 hr, and
the activation of MAP kinase (see below), which is not
detectable until 3 hr post-estradiol.
Estradiol-Enhanced Glutamate Release Does Not
Require Protein Synthesis but Does Require
Activation of PI3 Kinase
The rapid effect of estradiol on glutamate release from
hypothalamic neurons suggested a nongenomic mecha-
nism of action. Using 30 mMcycloheximide (CHX) to block
RNA translation, we tested whether estradiol-enhanced
neurotransmission required synthesis of new proteins.
Blocking protein synthesis had no effect on estradiol-enhanced
FM4-64 destaining in cultured hypothalamic neurons after 3 hr
(F3,24 = 3.66, p = 0.67; vehicle: n = 8, E2: n = 8, CHX + E2: n = 8,
CHX: n = 4 coverslips); however, CHX treatment did block the
estradiol-induced increase in spinophilin protein (F3,18 = 3.17,
p = 0.0498; vehicle: n = 6, E2: n = 6, CHX + E2: n = 6, CHX:
n = 4 coverslips; Figure 6A), confirming effective inhibition of
protein synthesis and a requirement for protein synthesis in the
promotion of spine formation. We conclude that estradiol can
enhance neurotransmitter release by activating ER; however,
the enhancement does not require the synthesis of new proteins.
A time course analysis of phosphorylation of the PI3 kinase
substrate Akt at ser473, using western blot, indicated that estra-
diol rapidly activated PI3 kinase within only 1 hr (F5,21 = 3.89, p =
0.048; Figure 6B), and that this activation was maintained at 3 hr
and 6 hr after estradiol treatment (p = 0.038 and p = 0.0247, re-
spectively; n = 4–5 coverslips for each group). The activation of
PI3 kinase by estradiol therefore just precedes the enhancement
of glutamate release, which occurs at 2–3 hr after treatment,588 Neuron 58, 584–598, May 22, 2008 ª2008 Elsevier Inc.
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ity. We tested this hypothesis by blocking PI3 kinase activation
with the specific inhibitor LY294002 (10 mM) and found that it
completely prevented estradiol-enhanced neurotransmitter re-
lease (F3.22 = 3.91, p = 0.023; vehicle: n = 7, E2: n = 7, LY + E2;
n = 8, LY: n = 4 coverslips; Figure 6B). If enhanced glutamate re-
lease via estradiol-induced activation of PI3 kinase is necessary
for increasing dendritic spine number, then blocking estradiol-
enhanced glutamate release with LY294002 would also block
the ability of estradiol to increase dendritic spines in these
neurons. As predicted, application of LY294002 also blocked
estradiol-induced formation of dendritic spines as determined
by western blot for spinophilin (F3,15 = 4.39, p = 0.003; n = 4–5
coverslips per group; Figure 6B).
These pharmacological experiments, taken together with the
time course of events, are consistent with a model in which es-
tradiol acts via ER to activate PI3 kinase via a nontranscriptional
mechanism, and PI3 kinase activation enhances presynaptic
glutamate release, thereby increasing postsynaptic AMPA and
NMDA receptor activation to induce spine formation.
Estradiol-Induced Glutamate Release Activates
MAP Kinase in the Postsynaptic Neuron to Increase
Dendritic Spines
Wealso determined that estradiol activates theMAP kinaseMEK
1/2, as seen by phosphorylation of its substrate ERK 1/2, just
prior to the estradiol-induced increase in spinophilin (Figure 7A).
By 3 hr post-estradiol treatment, there was significant activation
of MEK 1/2 (F2,12 = 6.60, p = 0.042) that was not seen at 1 hr but
Figure 4. Estradiol Enhances Glutamate Release from
Hypothalamic Neurons
(A) Representative EPSCs evoked from neurons treated with or
without estradiol (E2). Estradiol had no effect on the ratio of
AMPA (recorded at a holding potential of 80 mV) to NMDA (re-
corded at +40 mV) currents (t12 = 0.24; p = 0.81; Vehicle [Veh]:
n = 7, E2: n = 7).
(B) In the same neurons, EPSCs elicited with pairs of stimuli (inter-
stimulus interval = 50 ms, holding potential = 80 mV) indicated
that estradiol pretreatment significantly decreased the paired-
pulse ratio (amplitude of second EPSC divided by amplitude of
first EPSC), consistent with an increase in the probability of gluta-
mate release after estradiol treatment (t21 =2.72; *p < 0.05 com-
pared with vehicle).
Graphical representation of electrophysiological analysis indi-
cates the mean ± SEM for each treatment group.
was maintained for up to 6 hr after estradiol (p = 0.002;
Figure 7C). This time course suggests that activation
of MAP kinase by estradiol occurs at a point after the
enhanced release of glutamate, and that estradiol-in-
duced activation of MAP kinase occurs downstream
of glutamate receptor activation to induce dendritic
spine formation. This led to the prediction that block-
ing MAP kinase would have no effect on estradiol-en-
hanced neurotransmitter release in hypothalamic neu-
rons, and indeed blocking MAP kinase with PD98059
had no effect on estradiol-enhanced FM4-64 destain-
ing (F3,22 = 6.67, p = 0.169; vehicle: n = 7, E2: n = 7, PD + E2: n = 8,
PD: n = 4 coverslips; Figure 7A).
Earlier experiments revealed that treatment of females with the
glutamate receptor antagonists NBQX or MK801 completely
blocked estradiol-induced increases in spinophilin (see Figure 2).
In the same animals, NBQX treatment also completely blocked
the estradiol-induced activation of MAP kinase (F3,17 = 2.96,
p = 0.041; Figure 7B). We determined that treatment with
MK801 also prevented activation of MAP kinase by estradiol
in vivo (F3,17 = 4.79, p = 0.013; Figure 7B). Neither NBQX nor
MK801 treatment alone affected basal levels of MAP kinase.
These data confirm that activation of MAP kinase occurs
downstream of glutamate receptor activation in the developing
hypothalamus.
To determine if MAP kinase activity was required for the effect
of estradiol on dendritic spines, animals were pretreated with
PD98059 (200 ng intracerebroventricularly [ICV]). Indeed,
PD98059 blocked both the estradiol-induced activation of
MAP kinase (F3,16 = 7.91, p = 0.002; Figure 7C) and the increase
in spinophilin protein within 6 hr (F3,16 = 12.8, p = 0.002; Fig-
ure 7C). PD98059 treatment alone had no effect on spinophilin,
indicating that MAP kinase activity is not required to maintain
basal spinophilin levels in the MBH.
We also determined that estradiol promoted an increase in
spinophilin protein in cultured hypothalamic neurons generated
from E18 embryos and assayed on day in vitro 5 (DIV5) (Fig-
ure S4A). We used this in vitro model to test the role of other
kinases in the estradiol-induced increase in spinophilin. We
found that blocking MEK 1/2 or the c Jun kinase (JNK)Neuron 58, 584–598, May 22, 2008 ª2008 Elsevier Inc. 589
Neuron
E2 Increases Spines by Enhancing Glutamate ReleaseFigure 5. Estradiol Enhances Glutamate Release within 3 hr
(A) (Left upper panel) Photomicrograph of cultured hypothalamic neurons viewed under low magnification immediately prior to fluorescent FM4-64 imaging. The
rectangle represents the area of the neurite from the same cultured hypothalamic neuron viewed at higher magnification prior to FM4-64 imaging (DIC). Fluores-
cence image of the same neurite showing the punctate loading of FM4-64 dye at terminals is shown. Immediately to the right is a representative photomicrograph
of the gridded coverslip (Bellco) with an etched numbered grid (square = 0.6 mm 3 0.6 mm) used to identify neurons and terminals during imaging and after
fixation for VGLUT2 immunocytochemistry. Further to the right, representative pictures of both fluorescent FM4-64 labeling and the same boutons stained
with VGLUT2 indicate that the analyzed boutons were glutamatergic (Scale bars = 10 mm).
(B) (Left) Plots show the total mean ± SEM of fluorescence lost at each time point upon depolarization. Following depolarization with either 1 Hz electrical stim-
ulation or 50 mMKCl, neurons treated with estradiol (E2) exhibited an increased rate of destaining. (Right) Normalized fluorescence intensity values expressed as
a percent change frombaseline. Treatment with estradiol significantly increased the percentage of destaining after 30 s of depolarization induced by either 50mM
KCl or 1 Hz stimulation (F3,16 = 3.94; *p < 0.05 compared with vehicle [Veh]; Veh [1 Hz]: n = 3, Veh [50 mM]: n = 6, E2 [1 Hz]: n = 3, E2 [50 mM]: n = 8 coverslips).
(C) (Left) Plots show the total mean ± SEM of fluorescence lost at each time point upon depolarization with 50mMKCl. Treatment with estradiol increased the rate
of FM4-64 destaining in response to a depolarizing stimulus, and pretreatment of hypothalamic neurons with ICI completely blocked the estradiol-enhanced re-
lease of neurotransmitter (ANOVA F3,7 = 6.29; *p < 0.05 compared with all other groups; n = 3 coverslips per group). (Inset) In a separate analysis, neurons treated
with estradiol for less than 2 hr show enhanced neurotransmitter release compared with vehicle-treated neurons (t6 = 2.37; *p% 0.05 compared with vehicle).
Graphical representation of FM4-64 analysis indicates the mean ± SEM for each treatment group.590 Neuron 58, 584–598, May 22, 2008 ª2008 Elsevier Inc.
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of ERK 1/2 (F4,19 = 3.77, p = 0.013; Figure S4B) and increase
in dendritic spines (F4,19 = 8.38, p = 0.005; Figure S4C). Blocking
activation of p38 MAP kinase, also located in the hypothalamus,
had no significant effect on estradiol-induced ERK 1/2 activation
(p = 0.936) or levels of spinophilin (p = 0.074). In addition, block-
ing PKA (p = 0.130), protein kinase C (PKC) (p = 0.067), and
Cam Kinase II (CamKII) (p = 0.430) had no significant effect on
estradiol-induced spinophilin in the hypothalamic neurons
(Figure S5). We conclude that activation of glutamate receptors
at a time after which estradiol enhances glutamate release is
necessary for estradiol-induced activation of at least two
MAP kinases, MEK 1/2 and JNK, and possibly more. Conse-
quently, activation of multiple MAP kinases is a necessary com-
ponent of estradiol-induced dendritic spines in the developing
hypothalamus.
Enhancing Neurotransmitter Release with a-Latrotoxin
Mimics the Effect of Estradiol Treatment on Spinophilin
Levels
If estradiol promotes dendritic spine formation by enhancing
glutamate release from developing hypothalamic neurons,
then direct enhancement of neurotransmitter release should
mimic the effects of estradiol and increase spinophilin levels in
MBH neurons. To test this prediction, we treated cultured hypo-
thalamic neurons with estradiol (10 nM) as a positive control; the
estrogen receptor antagonist ICI (1mm) with or without estradiol;
or a-latrotoxin (3 pM). Latrotoxin is a secretagogue that at low
concentrations stimulates neurotransmitter release by facilitat-
ing the presynaptic exocytotic machinery (Capogna et al.,
1996). As seen previously, there was an overall effect of treat-
ment on spinophilin levels in hypothalamic neurons (F4,20 =
9.86, p = 0.001; Figure 8A). Specifically, treatment of neurons
with estradiol significantly increased spinophilin compared
with controls (p = 0.001, n = 5–6 coverslips). Pretreatment with
ICI blocked the estradiol-induced increase in spinophilin (p =
0.007 compared with estradiol-treated), but had no effect on
basal spinophilin (p = 0.439). Stimulation of glutamate release
with a-latrotoxin induced an increase in spinophilin similar to
that observed in estradiol-treated cultures (p = 0.68), under con-
ditions in which we demonstrated that ER were fully blocked by
ICI. With ER fully blocked, a-latrotoxin increased spinophilin
levels to those seen with estradiol treatment. This experiment
provides positive evidence that enhanced glutamate release
alone is sufficient to promote the formation of new dendritic
spines in the developing hypothalamus, and rules out any pos-
sible permissive postsynaptic role for ER activation in the induc-
tion of dendritic spines, suggesting a completely presynaptic
mechanism of estrogen action. In a separate experiment, we
also observed that combined a-latrotoxin and estradiol treat-
ment induced an increase in spinophilin expression (F3,26 =
3.65 main effect) that was not different from the increase in-
duced by either alone (p = 0.221 and p = 0.220; Figure 8B), sug-
gesting that a-latrotoxin occludes the effect of estradiol on
hypothalamic neurons. Therefore, enhancing neurotransmitter
release is sufficient to increase dendritic spines on developing
hypothalamic neurons.DISCUSSION
A major role of steroids in the adult brain is modulation of neuro-
nal plasticity, with an increasing emphasis on rapid but transient
effects (Balthazart and Ball, 2006). In marked contrast, estradiol
action in the developing brain permanently organizes the neural
substrate, making a rapid membrane-initiated effect an unlikely
mechanism by which this end would be achieved. To our sur-
prise, we have found that the initial event in estradiol-mediated
organization of dendritic spine synapses of the developing hypo-
thalamus begins with a transcription-independent activation of
PI3 kinase within 1 hr of steroid exposure, as demonstrated by
an increase in the phosphorylation of its substrate, Akt. The ac-
tivation of PI3 kinase was maintained for at least 6 hr under con-
tinuous estradiol exposure, as would be found in the developing
brain.
Consequent to PI3 kinase activation, we observed estradiol-
enhanced glutamate release from hypothalamic neurons both
in acutely prepared hypothalamic brain slices, as seen by a re-
duced PPR, and in primary cell cultures, as seen by examining
the release of FM4-64 from presynaptic terminals. Application
of a depolarizing stimulus, such as KCl or 1 Hz electrical stimu-
lation, evoked calcium-dependent neurotransmitter release
and destaining of FM4-64 from boutons that was significantly
faster in neurons incubated with estradiol for only 2–3 hr prior
to application of the depolarizing stimulus, compared with
vehicle-treated cultures. This action of estradiol on synaptic ex-
citation was entirely presynaptic; we detected no change in the
number or function of postsynaptic glutamate receptors.
Estradiol-enhanced glutamate release required activation of
PI3 kinase. Phosphoinositides are a key component of the mem-
braneand theirphosphorylation,byPI3kinase,producesasignal-
ingmolecule important for the recruitment andphosphorylationof
other proteins at the membrane (Cremona and De Camilli, 2001;
Di Paolo and De Camilli, 2006; Toker and Cantley, 1997). As a
result, they play an important role in the processes of exocytosis,
endocytosis, and trafficking of vesicles at the presynaptic mem-
brane (Cousin et al., 2003; Lin et al., 2001; Opazo et al., 2003; Yo-
komaku et al., 2003). Though the exact mechanism of action re-
mains unknown, phosphoinositides appear to act as a critical
regulatory component of neurotransmitter release. We found
that PI3 kinase inhibition did not block all neurotransmitter
release, suggesting that its role in estradiol-enhanced glutamate
release may be to facilitate the fusion of synaptic vesicles to the
target membrane (Rizzoli and Betz, 2002), via either changes in
the dynamics of the membrane itself or phosphorylation of the
proteins necessary for vesicle fusion (Cousin et al., 2003). PI3
kinase might also enhance glutamate release by facilitating the
mobilization of calcium into the terminal (Gong et al., 2005; Holt
et al., 2003; Mori et al., 2004). We conclude that the role of PI3 ki-
nase in glutamate release appears to be specific, because inhibi-
tion of MAP kinase had no effect on estradiol-enhanced gluta-
mate release; and blocking PKA, PKC, and CamKII had no
effect on estradiol-induced spinophilin. Moreover, there was no
effect of the protein synthesis inhibitor CHX on estradiol-
enhanced glutamate release, suggesting that the activation of
PI3 kinase by estradiol was due to a direct interaction between
the two proteins, presumably in the presynaptic membrane.Neuron 58, 584–598, May 22, 2008 ª2008 Elsevier Inc. 591
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E2 Increases Spines by Enhancing Glutamate ReleaseFigure 6. Estradiol Enhances Neurotransmitter Release via Nongenomic Activation of PI3 Kinase
(A) (Left) Plots show the total mean ± SEM of fluorescence lost at each time point upon depolarization with 50mMKCl. Treatment with estradiol (E2) increased the
rate of FM4-46 destaining in response to a depolarizing stimulus, and pretreatment of neurons with cycloheximide (CHX) had no effect on this increase. (Middle)
Normalized fluorescence intensity values are expressed as a percent change from baseline. Treatment with estradiol for 3 hr again increased the rate of FM4-64
destaining in response to a depolarizing stimulus (ANOVA F3,24 = 3.66; *p < 0.05 compared with vehicle [Veh] and CHX), and pretreatment with CHX, a translation
inhibitor, had no effect on estradiol-enhanced or baseline neurotransmitter release (Veh: n = 8, E2: n = 8, CHX + E2: n = 8, CHX: n = 4 coverslips). (Right) Western592 Neuron 58, 584–598, May 22, 2008 ª2008 Elsevier Inc.
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E2 Increases Spines by Enhancing Glutamate ReleaseThe estradiol-enhanced glutamate release and glutamate
receptor activation led to the activation of postsynaptic MAP
kinases, as demonstrated by increased phosphorylation of
ERK 1/2. This effect was delayed compared with the activation
of PI3 kinase, requiring at least 3 hr of estradiol exposure to be-
come apparent, further confirming the temporal sequence of
events. Blocking ionotropic glutamate receptors prevented acti-
vation of MAP kinase in response to estradiol, and inhibition of
the MAP kinases MEK 1/2 and JNK, but not p38 MAP kinase,
prevented the estradiol-mediated increase in spine number,
leading to the conclusion that activation of multiple MAP kinases
in the postsynaptic neuron is a consequence of enhanced gluta-
mate receptor activation and not the result of a direct activation
by the ER. Inhibiting MAP kinase prevented the estradiol-in-
duced increase in spinophilin, establishing a causal role of these
enzymes in new spine construction in this system. Phosphoryla-
tion of ERK is implicated in the reorganization of actin filaments
and is therefore capable of altering numerous cellular endpoints
including the targeting of mRNA to dendritic spines (Huang et al.,
2007), BK channel activation (O’Malley and Harvey, 2007), and
AMPA receptor reorganization at the spine (Kim et al., 2005;
Rumbaugh et al., 2006).
The observation that estradiol-induced signaling in the post-
synaptic neuron does not involve direct actions of the ER high-
lights an emerging role for cell-to-cell communication in ste-
roid-mediated organization of the developing brain. Advances
in themechanism of sexual differentiation of theDrosophila brain
highlight the importance of a single gene, fruitless (fru) (Manoli
et al., 2005), and further demonstrate that fru acts in a cell-auton-
omous manner to selectively change the morphology of individ-
ual neurons that express the protein (Kimura et al., 2005). One
might predict, given the restricted distribution and expression
of steroid receptors, that a similar potential exists in themamma-
lian brain. Both the current results and our previous findings es-
tablish that this is not the case. In the preoptic area (POA), an-
other brain region subject to estradiol-mediated organization of
synaptic patterning, the initiating event is increased production
of prostaglandin E2 (PGE2) following upregulation of the enzyme
COX-2 (Amateau andMcCarthy, 2004). Drawing on observations
that PGE2 induces glutamate release from astrocytes (Bezzi
et al., 1998), a working model proposes that in the POA the pros-
taglandin is released from the neuron and acts upon neighboring
astrocytes to induce glutamate release, which in turn acts back
on neurons to activate AMPA receptors and induce the formation
of dendritic spines. Therefore, in this brain region, neuronal-as-
trocytic-neuronal communication is essential. Similarly, neuronsin the arcuate nucleus of the hypothalamus undergo estradiol-
mediated sexual differentiation that begins in neurons with an in-
crease in GABA synthesis via upregulation of glutamic acid de-
carboxylase (GAD) (Mong et al., 2002). GABA is released from
the neurons, presumably nonsynaptically, and activates GABAA
receptors on neighboring astrocytes and induces growth and
branching of glial processes, i.e., stellation. Through mecha-
nisms that remain poorly understood, the differentiated astrocyte
communicates back to the neurons and suppresses the forma-
tion of new dendritic spines. Thus, in three circumstances in the
mammalian brain in which the cellular mechanisms establishing
sex differences in synaptic patterning have been well character-
ized, there is a defined role for cell-to-cell communication (Mc-
Carthy, 2008). The consequence of this mode of differentiation
is the potential for steroid-mediated differentiation of neuronal
morphology to extend beyond those cells that contain steroid re-
ceptors and to coordinate the organization of a more extensive
region of the neuropil. As a result, the optimal neural circuitry nec-
essary to integrate sensory and physiological stimuli for maxi-
mum reproductive fitness is obtained.
EXPERIMENTAL PROCEDURES
Animals
Female Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA)
maintained on a reverse 12 hr light/dark cycle and provided ad libitum food
and water were mated in our animal facility, and pregnancy was confirmed
by presence of sperm in a vaginal smear. Pregnant females were isolated
and allowed to deliver normally. Cages were checked regularly for presence
of pups to determine the time and day of birth (PN0). All animal experiments
were approved by the University of Maryland School of Medicine Institutional
Animal Care and Use Committee.
Drugs
All drugs were purchased from Sigma unless otherwise noted. The steroid
17b-estradiol (250 mg) was dissolved in ethyl oleate, which allows rapid
release. NBQX disodium salt was dissolved (2.5 mg/0.05 ml) in 0.9% saline.
MK801 was dissolved (10 mg/0.05 ml) in 0.9% saline. N-methyl-D-aspartate
was dissolved (10 mg/0.05 ml) in 0.9% saline. Biocytin was obtained from
Molecular Probes. PD98059 (Calbiochem) was dissolved (100 ng/ml) in 2%
DMSO for ICV injections.
Treatment of Pups
Estradiol and vehicle were injected s.c., and PD98059 was infused ICV 30 min
prior to treatment with estradiol or its vehicle. ICV infusions were performed by
penetrating the skin and skull with a beveled 23 gauge 1 ml Hamilton syringe
stereotaxically lowered to a predetermined depth of 2 mm before infusion of
1 ml over a 60 s period in cryoanesthetized animals. NBQX, MK801, NMDA,
and saline injections were given s.c. immediately before estradiol and againblot analysis for spinophilin protein indicates 30 mM CHX is a sufficient dose to block the synthesis of new proteins, including the estradiol-induced increase in
spinophilin seen 6 hr after treatment. (ANOVA F3,18 = 3.17; *p < 0.05 compared with all other groups). This further confirms that the estradiol-induced increase in
spinophilin is downstream of nongenomic enhancement of glutamate release (Veh: n = 6, E2: n = 6, CHX + E2: n = 8, CHX: n = 4 coverslips).
(B) (Left upper panel) Cultured hypothalamic neurons were treated with vehicle, estradiol, and/or LY294002 (LY), the PI3 kinase inhibitor, for 3 hr prior to FM4-64
imaging. Plots show the total mean fluorescence lost at each time point upon depolarization with 50 mM KCl. (Right upper panel) Normalized fluorescence in-
tensity values are expressed as a percent change from baseline. Treatment with estradiol for 3 hr increased the rate of FM4-64 destaining in response to a de-
polarizing stimulus (F3,22 = 3.91; *p < 0.05 compared with all other groups), and pretreatment with LY293002 blocked this increase (Veh: n = 7, E2: n = 7, LY + E2:
n = 8, LY: n = 4 coverslips). (Left lower panel) Estradiol significantly activates PI3 kinase as seen by the phosphorylation of its substrate Akt (ser473) within 1 hr, and
activation ismaintained for up to 6 hr after treatment (ANOVA F5,21 = 3.89; *p < 0.05 comparedwith vehicle, 10min E2 and 30min E2 [n = 4–5 coverslips per group]).
(Right lower panel) Treatment of cultured hypothalamic neurons with LY294002 also completely blocked the estradiol-induced increase in spinophilin protein as
seen by western blot analysis (ANOVA F3,15 = 4.39; *p < 0.05 compared with all other groups, n = 4–5 coverslips per group).
Graphical representation of FM4-64 analysis indicates the mean ± SEM for each treatment group.Neuron 58, 584–598, May 22, 2008 ª2008 Elsevier Inc. 593
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E2 Increases Spines by Enhancing Glutamate ReleaseFigure 7. Estradiol Activates MAP Kinase Downstream of Glutamate Receptor Activation to Induce Dendritic Spine Formation
(A) (Left) Cultured hypothalamic neurons were treated with vehicle (Veh), estradiol (E2), and/or PD98059 (PD), a potent MEK 1/2 inhibitor, for 3 hr prior to FM4-64
imaging. Plots show the total mean ± SEMof fluorescence lost at each time point upon depolarization with 50mMKCl. (Middle) Normalized fluorescence intensity
values are expressed as percent change from baseline. Treatment with estradiol for 3 hr increased the rate of FM4-64 destaining in response to a depolarizing
stimulus, and pretreatment with PD98059 had no effect on estradiol-enhanced destaining (ANOVA F3,22 = 6.67; *p < 0.05 compared with vehicle and PD; Veh:
n = 7, E2; n = 7, PD + E2: n = 8, PD: n = 4 coverslips). (Right) Estradiol treatment significantly increased activation of MAP kinase within 3 hr, as seen by the594 Neuron 58, 584–598, May 22, 2008 ª2008 Elsevier Inc.
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E2 Increases Spines by Enhancing Glutamate Release4 hours after estradiol injection. Exactly 6 hr after treatment, animals were
euthanized and the MBH was isolated (Figure 1B).
Golgi-Cox Impregnation and Biocytin Analysis
PN0 rats were separated and treated according to the following groups: (1)
males + vehicle, (2) females + vehicle, (3) females + 250 mg 17b-estradiol
and (4) females + 10 mgNMDA. Six hours after treatment, brains were collected
and processed for Golgi impregnation as previously described (Mong et al.,
1999; Todd et al., 2007). After processing of both Golgi and biocytin-filled
neurons, five neurons from each were analyzed for the number of dendritic
spines (>5 mm) on each primary dendrite and the length of the primary dendrite
(including all branch lengths extending from that dendrite). Data were analyzed
with one-way ANOVA, a < 0.05, and Tukey’s post hoc when appropriate.
Western Immunoblot
Brain tissue from treated animals and hypothalamic cultures was homoge-
nized in lysis buffer and prepared as described previously (Amateau and
McCarthy, 2002a; Todd et al., 2007; and details provided in Supplementary
Methods.)
Whole-Cell Patch-Clamp Recordings and Hypothalamic Brain Slice
Preparation
For evoked excitatory postsynaptic currents (eEPSC), female pups were
treated on PN2 with estradiol (250 mg/0.1 ml ethyl oleate) or vehicle and
collected 6 hr later. For mEPSCs, female rat pups were treated with estradiol
(100 mg/0.1 ml) or vehicle once a day each day from PN0 to PN2 and collected
on PN4–5. Coronal hypothalamic slices (400 mm) containing the VMN region
(Figure 3B) were prepared using a Vibratome (Vibratome series 1000, St. Louis,
MO) in ice-cold sucrose solution, where NaCl in the artificial cerebral spinal
fluid (ACSF) was replaced by an isosmotic concentration of sucrose. Slices
were then incubated at 34C for 20min, and then allowed to recover for at least
1 hr at room temperature (RT) before experimentation. For evoked EPSCs,
vehicle (DMSO 0.01%) or estradiol (10 nM) was included in the ACSF solution
during slice preparation and recordings in vehicle-pretreated or estradiol-pre-
treated animals, respectively. The osmolarity of all solutions used was
305–315 mOsm. Details regarding the recording of eEPSCs and mEPSCs
can be found in the Supplemental Methods.
Electrophysiological Data Analysis
Cumulative probability distributions of mEPSC amplitude were created either
from control or treated cells. Evoked EPSC amplitude was computed from
an average of ten consecutive responses. The amplitude of NMDA-receptor-
mediated currents, recorded with the cell voltage-clamped at +40 mV, were
collected at 60 ms following the stimulation, a time at which AMPA-receptor-
mediated currents had completely decayed. The ratios of AMPA and NMDA
amplitudes were calculated in consecutive time periods with unchanged stim-
ulation parameters. The PPR was calculated as the average amplitude of the
second of two EPSCs elicited with extracellular stimuli separated by 50 ms,
divided by the average amplitude of the first EPSC in the pair. For these
data, ten individual trials were analyzed and the PPR was computed from
the averaged trace. Data were expressed as mean ± SEM, and p values
Figure 8. Evoked Neurotransmitter Release
Increases Spinophilin Levels in Hypotha-
lamic Neurons
(A) Treatment of cultured hypothalamic neurons
with estradiol significantly increases levels of
spinophilin protein, and pretreatment with the es-
trogen receptor (ER) antagonist ICI prevents this
increase. Treatment of neurons with the secreta-
gogue a-latrotoxin to evoke neurotransmitter re-
lease recovers the effect of blocking ER and in-
creases spinophilin to levels seen with estradiol
treatment alone (ANOVA F4,20 = 9.86; p = 0.001
compared with vehicle). ICI alone has no effect
on spinophilin (p = 0.439, data not shown; n = 5–
6 coverslips per group).
(B) In a separate experiment, treatment of cultured
hypothalamic neurons with a-latrotoxin evokes
neurotransmitter release and also increases spi-
nophilin to the levels seen with estradiol treatment
(ANOVA F3,26 = 3.65; p < 0.05 compared with
vehicle). Combined estradiol and a-latrotoxin
treatment does not induce spinophilin levels that
surpass those seen with either drug alone (p =
0.22; n = 6–8 per group).
Graphical representationofwesternblot analysis in-
dicates the mean ± SEM for each treatment group.
phosphorylation of its substrate, phospho ERK 1/2 (ANOVA F2,12 = 6.60; *p < 0.05 compared with other groups). Estradiol had no effect on phospho ERK 1/2 at
1 hr (Veh: n = 6, E2 1 hr: n = 5, E2 3 hr: n = 4 animals).
(B) (Left) In the same animals from Figure 2A, estradiol treatment for 6 hr induced a 2-fold increase in the activation of MAP kinase, as seen by phosphorylation of
ERK 1/2, and pretreatment with the AMPA receptor antagonist NBQX completely blocked the activation of MAP kinase (ANOVA F3,17 = 2.96; *p < 0.05 compared
with all other groups; n = 5–6 animals per group). (Right) In the same animals from Figure 2A, estradiol treatment significantly increased phosphorylation of ERK
1/2, and pretreatment with the NMDA receptor antagonist MK801 completely blocked the estradiol-induced activation of MAP kinase (F3,17 = 4.79; *p < 0.05
compared with all other groups; n = 5–6 animals per group).
(C) (Left) Pretreatment of females with PD98059 completely blocked estradiol-induced activation of MAP kinase as seen by phosphorylation of ERK 1/2 (ANOVA
F3,16 = 7.91; *p < 0.05 compared with all other groups; n = 5 animals per group). (Right) In the same tissue, estradiol treatment significantly increased spinophilin
levels, and pretreatment with PD98059 blocked the estradiol-induced increase in spinophilin in the MBH (ANOVA F3,16 = 12.8; *p < 0.05 compared with all other
groups; n = 5 animals per group).
Graphical representation of FM4-64 and western blot analysis indicates the mean ± SEM for each treatment group.Neuron 58, 584–598, May 22, 2008 ª2008 Elsevier Inc. 595
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E2 Increases Spines by Enhancing Glutamate Releasewere derived from Student’s unpaired t test, with significance levels assessed
at p < 0.05 unless otherwise noted.
Hypothalamic Cultures
Timed pregnant Sprague-Dawley female rats purchased from Charles River
Laboratories (Wilmington, MA) were killed on gestational day 18. The hypothal-
ami were dissected from the brains of approximately 8–9 fetal rats and cultured
as described in Perrot-Sinal et al. (2001). Cells were plated onto poly-L-lysine-
coated glass coverslips at a density of 250,000 cells/plate with platingmedium
for western blot experiments and 150,000 cells/plate for imaging experiments
(FM and calcium) in 2 ml of sterile culture medium (SCM). Plates were
maintained in an incubator at 37C and 5% CO2 for 5 days in vitro before
use. Plating occurred onDIV1. Culturemediumwas changed one time onDIV3.
Treatment of Cultured Neurons
For experiments involving FM4-64 imaging, cultures were treated for 3 or 6 hr
with 10 nM 17b-estradiol or vehicle prior to imaging on DIV5. Pretreatment with
antagonists such as ICI (Tocris 1 mM in DMSO), PD98059 (10 mM in DMSO),
LY294002 (10 mM in DMSO), or CHX (30 mM in ethanol) occurred 30 min prior
to estradiol or DMSO treatment. a-Latrotoxin (Calbiochem) was administered
in saline at 3 pM in combination or separately from estradiol.
FM4-64 Imaging and Analysis
Hypothalamic neurons used for FM4-64 imagingwere plated on gridded cover-
slips (Bellco Biotechnology), rinsed in an equilibrating buffer for 15 min, and
loadedwith2mMFM4-64 (SynaptoRed) usinga loadingbuffer for 10min. Imme-
diately thereafter, neurons were washed in a rinsing buffer (see Supplemental
Methods) for 10min. Imageswere captured (red600–700nmemission filter) ev-
ery 3 s tominimize photobleaching. After approximately 30 s of establishing the
baseline fluorescence, the neuronswere rinsed for 60 swith anunloadingbuffer
(seeSupplementalMethods) containing50mMKClor stimulatedat 1Hzwithan
extracellular electrode placed in the bath. After2min of image capture during
destaining, unloading of the terminals continued for another 5 min to obtain
a picture of the completely destained puncta. This image was considered to
represent nonspecific stainingandwas subtracted fromall imagesprior to anal-
ysis. Images were analyzed using SimplePCI imaging software (Hamamatsu
Inc.). The destaining rate was determined from the change in fluorescence
emission over time as described in Brager et al. (2003), Pyle et al. (1999), and
Ryanet al. (1996). Themean total fluorescence lost fromall boutonsononecov-
erslip was averaged, and this value was then averaged with other coverslips
treated identically (n = 1 coverslip, 3–4 separate culture runs per experiment).
Themean total fluorescence lostwas compared across treatment groups using
a one-way ANOVA. Criterion for significance levels was a < 0.05. Neurons an-
alyzed for the rate of neurotransmitter release were also analyzed for the num-
ber of loaded boutons and the area of each bouton.
Immunocytochemistry for VGLUT2
Immediately after imaging, coverslips with adhered cells were fixed and
prepared for immunocytochemical detection with anti-vesicular glutamate
transporter 2 (VGLUT2; Sigma, 1:1,000), then developed as described previ-
ously (Speert et al., 2007).
SUPPLEMENTAL DATA
The Supplemental Data for this article can be found online at http://www.
neuron.org/cgi/content/full/58/4/584/DC1/.
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